These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treating lipid abnormalities in patients with type 2 diabetes mellitus. Steiner G Am J Cardiol; 2001 Dec; 88(12A):37N-40N. PubMed ID: 11788129 [TBL] [Abstract][Full Text] [Related]
24. Lipid-lowering therapy and macrovascular disease in diabetes mellitus. Garg A Diabetes; 1992 Oct; 41 Suppl 2():111-5. PubMed ID: 1526329 [TBL] [Abstract][Full Text] [Related]
25. [Dyslipoproteinemia and diabetes mellitus]. Vaverková H Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647 [TBL] [Abstract][Full Text] [Related]
26. [Diabetes mellitus complicated with hyperlipidemia]. Ota Y; Gotoda T Nihon Rinsho; 2002 Oct; 60 Suppl 10():424-9. PubMed ID: 12430264 [No Abstract] [Full Text] [Related]
27. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients. Hamilton SJ; Chew GT; Davis TM; Watts GF Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial assessment of lipid-acting drugs in diabetic patients. Steiner G Am J Cardiol; 1998 Apr; 81(8A):58F-59F. PubMed ID: 9604911 [No Abstract] [Full Text] [Related]
34. Treatment of lipid disorders in diabetes mellitus. Dunn FL Med Clin North Am; 1988 Nov; 72(6):1379-98. PubMed ID: 3054359 [TBL] [Abstract][Full Text] [Related]
35. Lipid management in diabetic patients: lessons from prevention trials. Gotto AM Am J Med; 2002 Jun; 112 Suppl 8A():19S-26S. PubMed ID: 12049991 [TBL] [Abstract][Full Text] [Related]
36. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions]. Braschi S Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575 [TBL] [Abstract][Full Text] [Related]
37. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence. Pyörälä K; Steiner G Ann Med; 1996 Aug; 28(4):357-62. PubMed ID: 8862691 [TBL] [Abstract][Full Text] [Related]
38. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events. Davidson MH Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853 [No Abstract] [Full Text] [Related]
40. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]